Gujarat Themis Biosyn Soars After ₹1,300 Crore Japanese Acquisition
Gujarat Themis Biosyn’s Strategic Leap: A ₹1,300 Crore Acquisition of a Japanese Firm A Bold Move in the Biopharmaceutical Landscape Gujarat Themis Biosyn has...
Read Article